Synta Pharmaceuticals Corp (NASDAQ:SNTA)
| 3.95 Data as of 12:17pm ET |  -0.055 / -1.38%Today’s Change | 3.76 Today|||52-Week Range 11.88 | -56.26% Year-to-Date |
Latest SNTA News | Press Releases
| 3 Horrendous Health-Care Stocks This Week Jun 14 / MotleyFool.com | Post-ASCO Movers: Are Any a Buy? Jun 05 / MotleyFool.com |
Today’s Trading
| Previous close | 4.00 |
| Today’s open | 3.98 |
| Day’s range | 3.92 - 4.02 |
| Volume | 344,579 |
| Average volume (3 months) | 1,320,894 |
| Market cap | $276.5M |
| Dividend yield | -- |
Data as of 12:17pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -6.00% |
| Earnings growth (this year) | -12.54% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VICLVical Inc | +0.05 | +1.62% |
| SNSSSunesis Pharmaceutic... | +0.04 | +0.78% |
| SCLNSciClone Pharmaceuti... | -0.02 | -0.41% |
| XNPTXenoport Inc | -0.09 | -1.66% |
Data as of 12:32pm ET, 06/19/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$62.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Safi R. Bahcall, PhD |
Chief Financial Officer & VP-Administration Keith S. Ehrlich, MBA, CPA |
Corporate headquarters Lexington, Massachusetts |
Forecasts
